81 |
Engineering novel suicide enzymes for improved cancer gene therapyArdiani, Andressa. January 2009 (has links) (PDF)
Thesis (Ph. D.)--Washington State University, May 2009. / Title from PDF title page (viewed on June 15, 2009). "School of Molecular Biosciences." Includes bibliographical references.
|
82 |
Factors influencing intention to obtain a genetic test for prostate cancer risk : a structural equation modeling approach /Wayne, Melissa Kezis. January 2004 (has links)
Thesis (Ph. D.)--Drexel University, 2004. / Includes abstract and vita. Includes bibliographical references (leaves 115-125).
|
83 |
The construction and evaluation of a tool for the assessment of cancer pain in a Chinese context /Chung, Wai-yee. January 1998 (has links)
Thesis (Ph. D.)--University of Hong Kong, 1998. / Includes bibliographical references (leaves 272-287).
|
84 |
Pharmacogenomic and mechanistic studies on dietary factors in chemoprevention of cancerNair, Sujit Sukumar. January 2008 (has links)
Thesis (Ph. D.)--Rutgers University, 2008. / "Graduate Program in Pharmaceutical Science." Includes bibliographical references (p. 311-331).
|
85 |
DNA methylation and pediatric cancerChan, Kwai-yi, Jacqueline. January 2002 (has links)
Thesis (M.Med.Sc.)--University of Hong Kong, 2002. / Includes bibliographical references (leaves 83-101). Also available in print.
|
86 |
Cancer deaths in the aged psychosocial and disease variables /Cason, Laura Rose, January 1985 (has links)
Thesis (Ph. D.)--University of Florida, 1985. / Description based on print version record. Typescript. Vita. Includes bibliographical references (leaves 205-214).
|
87 |
An empirical study of a rehabilitation program for fatigue related to cancerQuestad, Kent Arthur. January 1900 (has links)
Thesis (Ph. D.)--University of Wisconsin--Madison, 1983. / Typescript. Vita. eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references (leaves 70-73).
|
88 |
Validation of a Chinese version of the quality of life factors (QF) questionnaire among cancer patients in Hong Kong /Chan, Yuk-pui, Rose. January 2005 (has links)
Thesis (M. Med. Sc.)--University of Hong Kong, 2005.
|
89 |
Quantitative optical imaging for the detection of early cancer /Wu, Tao. January 2007 (has links)
Thesis (Ph.D.)--Hong Kong University of Science and Technology, 2007. / Includes bibliographical references (leaves 151-166). Also available in electronic version.
|
90 |
Rôle de Lano/LRRC1 dans le cancer du sein et influence sur les cellules souches cancéreuses / Role of Lano/LRRC1 in breast cancer and influence in cancer stem cellsLopez Almeida, Leonor 15 December 2017 (has links)
Les chiffres mondiaux estiment l’incidence du cancer du sein, cancer féminin le plus fréquent, à 1.3 millions de cas par an, dont près d’un tiers a une issue fatale.La polarité est indispensable à l’organisation cellulaire, ses défauts peuvent mener au cancer. Notre projet est focalisé sur une protéine de la polarité, Lano, et son influence sur le cancer du sein et les CSC. L’Institut Paoli-Calmettes dispose d’environ 10000 échantillons de cancer du sein dont l’analyse montre que la perte de Lano est corrélée à des cancers du sein plus graves et à une augmentation des CSC. Nos résultats in vitro, sur des cellules de cancer du sein humain et in vivo montrent aussi que Lano est un régulateur du nombre de CSC. Les CSC sont une ces causes principales de rechute des patients. La suite de nos travaux pourrait déterminer si Lano est un facteur pronostique de la maladie ou une cible thérapeutique possible. / Breast cancer is the most common cancer in women. Worldwide figures estimate the incidence of breast cancer at 1.3 million cases per year, nearly one third of them has a fatal outcome.Our project focuses on the study of Lano, a polarity protein, in breast cancer and stem cells. The hospital “Institute Paoli-Calmettes” gathered 10,000 breast cancer samples whose analysis shows that the loss of Lano has a role in breast cancer and stem cells. Our in vitro results on human breast cancer cells and in vivo also show that Lano is a regulator of the number of cancer stem cells. Cancer stem cells are one of the major causes of relapse in patients. The rest of our work could determine if Lano could be a prognostic factor of the disease or a possible therapeutic target.
|
Page generated in 0.052 seconds